Compound Evidence File
#EC-2026-0361
Alprostadil
Filed under Peptides. The bureau holds 162 laboratory returns for this compound from 64 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
64 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 4 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 4 | 10.0 | 9.9 | 10.0 | 3 Jul 2026 | 13 Aug 2026 |
| AsymchemCASE #VI-2026-0091 | A | 4 | 10.0 | 10.0 | 10.0 | 23 Feb 2026 | 13 Jul 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 3 | 10.0 | 10.0 | 10.0 | 6 Mar 2026 | 4 May 2026 |
| BachemCASE #VI-2026-0314 | A | 3 | 10.0 | 10.0 | 10.0 | 2 Apr 2026 | 4 Jul 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 3 | 10.0 | 9.9 | 10.0 | 21 May 2026 | 11 Jul 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 3 | 10.0 | 10.0 | 10.0 | 16 Jan 2026 | 13 Jun 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 3 | 10.0 | 9.9 | 10.0 | 25 Nov 2025 | 10 Jul 2026 |
| SinoPepCASE #VI-2026-0387 | A | 3 | 10.0 | 9.9 | 10.0 | 23 May 2026 | 10 Jun 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 2 | 10.0 | 10.0 | 10.0 | 18 Nov 2025 | 27 Jun 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 2 | 10.0 | 10.0 | 10.0 | 4 Jun 2026 | 8 Jul 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 2 | 10.0 | 10.0 | 10.0 | 7 Apr 2026 | 15 May 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 5 | 9.9 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 4 | 9.9 | 9.9 | 10.0 | 1 Apr 2026 | 18 Jun 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 4 | 9.9 | 9.9 | 9.9 | 3 Jan 2026 | 6 Jun 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 3 | 9.9 | 9.9 | 10.0 | 19 May 2026 | 4 Jul 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 3 | 9.9 | 9.9 | 10.0 | 10 May 2026 | 25 Jun 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 3 | 9.9 | 9.9 | 9.9 | 19 Jun 2026 | 2 Aug 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 2 | 9.9 | 9.9 | 10.0 | 6 Jun 2026 | 22 Jun 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 2 | 9.9 | 9.9 | 10.0 | 8 Jan 2026 | 12 Apr 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 2 | 9.9 | 9.9 | 10.0 | 17 Jun 2026 | 26 Jun 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 2 | 9.9 | 9.9 | 10.0 | 7 Apr 2026 | 27 Apr 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 2 | 9.9 | 9.9 | 10.0 | 18 Jul 2026 | 28 Jul 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 5 | 9.3 | 7.5 | 10.0 | 24 May 2026 | 24 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 5 | 8.7 | 8.1 | 9.4 | 21 May 2026 | 21 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 8 | 8.4 | 7.2 | 9.4 | 24 May 2026 | 24 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 4 | 8.3 | 7.4 | 9.4 | 24 May 2026 | 24 May 2026 |
| Royal PeptidesCASE #VI-2026-0264 | X | 1 | 8.0 | 8.0 | 8.0 | 21 May 2025 | 21 May 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 8 | 7.8 | 7.0 | 8.5 | 24 May 2026 | 24 May 2026 |
| Peptide-SCASE #VI-2026-0111 | X | 8 | 7.7 | 3.6 | 9.8 | 2 Apr 2025 | 24 May 2026 |
| Hangzhou Mandy BiotechnologyCASE #VI-2026-0695 | X | 1 | 7.6 | 7.6 | 7.6 | 3 Jul 2025 | 3 Jul 2025 |
| Xian Yihang TechnologyCASE #VI-2026-0656 | X | 1 | 7.5 | 7.5 | 7.5 | 13 Jun 2025 | 13 Jun 2025 |
| YimeiCASE #VI-2026-0081 | X | 3 | 7.4 | 6.1 | 8.9 | 8 Jul 2025 | 21 May 2026 |
| Xingtai Pukelai Technology CoCASE #VI-2026-0850 | X | 1 | 7.4 | 7.4 | 7.4 | 27 Feb 2025 | 27 Feb 2025 |
| M-PeptidesCASE #VI-2026-0442 | X | 1 | 7.3 | 7.3 | 7.3 | 2 Apr 2025 | 2 Apr 2025 |
| Reta-PeptideCASE #VI-2026-0756 | X | 9 | 7.1 | 3.6 | 10.0 | 6 May 2025 | 20 May 2026 |
| Haikou Mingheng TechnologyCASE #VI-2026-0250 | X | 1 | 6.9 | 6.9 | 6.9 | 3 Jun 2025 | 3 Jun 2025 |
| Paramount PeptidesCASE #VI-2026-0550 | X | 1 | 6.9 | 6.9 | 6.9 | 6 May 2025 | 6 May 2025 |
| Evolve BioPepCASE #VI-2026-0755 | X | 1 | 6.7 | 6.7 | 6.7 | 16 Mar 2025 | 16 Mar 2025 |
| PurePeptidesCASE #VI-2026-0234 | X | 1 | 6.6 | 6.6 | 6.6 | 6 May 2025 | 6 May 2025 |
| Chimera PeptidesCASE #VI-2026-0260 | X | 1 | 6.5 | 6.5 | 6.5 | 9 Jun 2025 | 9 Jun 2025 |
| Diju Peptides Wellness and CoCASE #VI-2026-0724 | X | 1 | 6.5 | 6.5 | 6.5 | 24 Apr 2025 | 24 Apr 2025 |
| The Naughty NeedleCASE #VI-2026-0432 | X | 1 | 6.3 | 6.3 | 6.3 | 13 Feb 2025 | 13 Feb 2025 |
| Polaris PeptidesCASE #VI-2026-0839 | X | 5 | 6.2 | 5.4 | 6.8 | 6 May 2025 | 24 May 2026 |
| Amplified AminoCASE #VI-2026-0748 | X | 1 | 6.2 | 6.2 | 6.2 | 7 May 2025 | 7 May 2025 |
| Shandong Nuoweiou Medical Technology CoCASE #VI-2026-0076 | X | 1 | 6.2 | 6.2 | 6.2 | 13 Feb 2025 | 13 Feb 2025 |
| Elite Research USACASE #VI-2026-0267 | X | 4 | 6.1 | 3.5 | 7.4 | 21 May 2025 | 26 Jan 2026 |
| Shanghai JinBei Chemical TechnologyCASE #VI-2026-0107 | X | 1 | 6.0 | 6.0 | 6.0 | 7 May 2025 | 7 May 2025 |
| Shanghai Leader Peptide BiotechnologyCASE #VI-2026-0558 | X | 1 | 5.9 | 5.9 | 5.9 | 6 May 2025 | 6 May 2025 |
| Yongkang Nuoao Trading CoCASE #VI-2026-0646 | X | 1 | 5.7 | 5.7 | 5.7 | 8 Jul 2025 | 8 Jul 2025 |
| Welon Peptide SolutionsCASE #VI-2026-0478 | X | 1 | 5.4 | 5.4 | 5.4 | 13 Feb 2025 | 13 Feb 2025 |
| UWA Elite PeptidesCASE #VI-2026-0130 | X | 1 | 5.3 | 5.3 | 5.3 | 7 May 2025 | 7 May 2025 |
| Allen Biotechnology Co ABCCASE #VI-2026-0709 | X | 4 | 5.0 | 4.2 | 6.0 | 21 May 2025 | 24 May 2026 |
| HazelCASE #VI-2026-0392 | X | 1 | 4.8 | 4.8 | 4.8 | 28 Mar 2025 | 28 Mar 2025 |
| Eros PeptidesCASE #VI-2026-0918 | X | 1 | 4.6 | 4.6 | 4.6 | 11 Jun 2025 | 11 Jun 2025 |
| Oasis PeptidesCASE #VI-2026-0404 | X | 1 | 4.6 | 4.6 | 4.6 | 14 Jan 2025 | 14 Jan 2025 |
| Prime PeptidesCASE #VI-2026-0696 | X | 1 | 4.3 | 4.3 | 4.3 | 16 Mar 2025 | 16 Mar 2025 |
| Modern AminosCASE #VI-2026-0635 | X | 1 | 4.2 | 4.2 | 4.2 | 13 Jun 2025 | 13 Jun 2025 |
| Liberty PeptidesCASE #VI-2026-0416 | X | 1 | 4.2 | 4.2 | 4.2 | 3 Jun 2025 | 3 Jun 2025 |
| Peptides For SaleCASE #VI-2026-0614 | X | 2 | 3.9 | 3.0 | 4.8 | 9 Jun 2025 | 23 May 2026 |
| Biolabshop LimitedCASE #VI-2026-0832 | X | 1 | 3.1 | 3.1 | 3.1 | 6 May 2025 | 6 May 2025 |
| Lejian Biotech PeptideCASE #VI-2026-0746 | X | 1 | 3.0 | 3.0 | 3.0 | 28 Mar 2025 | 28 Mar 2025 |
| Peptides 4 ResearchCASE #VI-2026-0511 | X | 1 | 2.3 | 2.3 | 2.3 | 21 May 2025 | 21 May 2025 |
| PepKitsCASE #VI-2026-0320 | X | 1 | 1.4 | 1.4 | 1.4 | 9 Jun 2025 | 9 Jun 2025 |
Open any subject to view the batch-level evidence for Alprostadil alone.